DE602004017888D1 - Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure - Google Patents
Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäureInfo
- Publication number
- DE602004017888D1 DE602004017888D1 DE602004017888T DE602004017888T DE602004017888D1 DE 602004017888 D1 DE602004017888 D1 DE 602004017888D1 DE 602004017888 T DE602004017888 T DE 602004017888T DE 602004017888 T DE602004017888 T DE 602004017888T DE 602004017888 D1 DE602004017888 D1 DE 602004017888D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- stupidation
- hyaluronic
- acute
- excessive injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 4
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 230000006378 damage Effects 0.000 title 1
- 208000014674 injury Diseases 0.000 title 1
- 230000020477 pH reduction Effects 0.000 title 1
- 206010024453 Ligament sprain Diseases 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000010040 Sprains and Strains Diseases 0.000 abstract 2
- 210000004872 soft tissue Anatomy 0.000 abstract 2
- 206010065303 Medial Tibial Stress Syndrome Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51068403P | 2003-10-09 | 2003-10-09 | |
| PCT/CA2004/001579 WO2005032562A1 (en) | 2003-10-09 | 2004-08-27 | Methods for treating acute and overuse sprain and strain using hyaluronic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004017888D1 true DE602004017888D1 (de) | 2009-01-02 |
Family
ID=34421822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004017888T Expired - Lifetime DE602004017888D1 (de) | 2003-10-09 | 2004-08-27 | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050080037A1 (de) |
| EP (1) | EP1677806B1 (de) |
| JP (4) | JP2007507431A (de) |
| CN (1) | CN1859918B (de) |
| AT (1) | ATE414522T1 (de) |
| AU (1) | AU2004277290B2 (de) |
| CA (1) | CA2541813C (de) |
| DE (1) | DE602004017888D1 (de) |
| DK (1) | DK1677806T3 (de) |
| ES (1) | ES2317018T3 (de) |
| PL (1) | PL1677806T3 (de) |
| PT (1) | PT1677806E (de) |
| SI (1) | SI1677806T1 (de) |
| WO (2) | WO2005032562A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2537751T3 (es) * | 2004-12-30 | 2015-06-11 | Genzyme Corporation | Regímenes para viscosuplementación intraarticular |
| CA2633978A1 (en) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects |
| WO2007070547A2 (en) * | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| MX2008014403A (es) * | 2006-05-11 | 2009-03-23 | Sandra Gobbo | Mezclas binarias del acido hialuronico y su uso terapeutico. |
| US9072779B2 (en) | 2009-01-07 | 2015-07-07 | Robert John Petrella | Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
| IT1394570B1 (it) * | 2009-07-02 | 2012-07-05 | Fidia Farmaceutici | Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni. |
| TWI383796B (zh) | 2009-08-14 | 2013-02-01 | Holy Stone Healthcare Co Ltd | Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer |
| TWI516269B (zh) | 2009-08-14 | 2016-01-11 | 禾伸堂生技股份有限公司 | 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物 |
| US20110166099A1 (en) * | 2010-01-04 | 2011-07-07 | Wu Tsung-Chung | Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
| US8722644B2 (en) | 2010-01-04 | 2014-05-13 | Holy Stone Healthcare Co., Ltd. | Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
| US20110166098A1 (en) * | 2010-01-04 | 2011-07-07 | Wu Tsung-Chung | Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| US8575130B2 (en) * | 2010-01-04 | 2013-11-05 | Holy Stone Healthcare Co., Ltd. | Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| US9029347B2 (en) | 2010-08-05 | 2015-05-12 | Holy Stone Healthcare Co., Ltd. | Method and mixture for treating and preventing inflammatory bowel disease |
| EP2545925B1 (de) | 2011-07-12 | 2018-02-14 | Holy Stone Healthcare Co.,Ltd. | Zusammensetzung enthaltend Hyaluronsäure zur Behandlung und Verhinderung von Schleimhauterkrankungen |
| WO2014110656A1 (en) * | 2013-01-17 | 2014-07-24 | Hagel Jeffrey | Increasing muscular volume in a human using hyaluronic acid |
| CN106860706A (zh) * | 2015-12-10 | 2017-06-20 | 仲伟波 | 双液删刺药液 |
| AU2017257956B2 (en) | 2016-04-27 | 2019-11-07 | Anika Therapeutics, Inc. | Compositions for use in treating tendon degeneration |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| US4808576A (en) * | 1986-04-28 | 1989-02-28 | Mobay Corporation | Remote administration of hyaluronic acid to mammals |
| US5079236A (en) * | 1987-05-27 | 1992-01-07 | Hyal Pharmaceutical Corporation | Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
| US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| MXPA01011542A (es) * | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel. |
| ES2374157T3 (es) * | 2002-10-16 | 2012-02-14 | Arthrodynamic Technologies, Animal Health Division, Inc. | Tratamiento para la sinovitis traumática y el cartílago articular dañado. |
-
2004
- 2004-08-27 PL PL04761743T patent/PL1677806T3/pl unknown
- 2004-08-27 ES ES04761743T patent/ES2317018T3/es not_active Expired - Lifetime
- 2004-08-27 CN CN2004800282820A patent/CN1859918B/zh not_active Expired - Lifetime
- 2004-08-27 DE DE602004017888T patent/DE602004017888D1/de not_active Expired - Lifetime
- 2004-08-27 AU AU2004277290A patent/AU2004277290B2/en not_active Ceased
- 2004-08-27 CA CA2541813A patent/CA2541813C/en not_active Expired - Lifetime
- 2004-08-27 PT PT04761743T patent/PT1677806E/pt unknown
- 2004-08-27 EP EP04761743A patent/EP1677806B1/de not_active Expired - Lifetime
- 2004-08-27 AT AT04761743T patent/ATE414522T1/de active
- 2004-08-27 WO PCT/CA2004/001579 patent/WO2005032562A1/en active Application Filing
- 2004-08-27 DK DK04761743T patent/DK1677806T3/da active
- 2004-08-27 US US10/927,526 patent/US20050080037A1/en not_active Abandoned
- 2004-08-27 SI SI200431038T patent/SI1677806T1/sl unknown
- 2004-08-27 JP JP2006529508A patent/JP2007507431A/ja not_active Withdrawn
- 2004-10-08 WO PCT/IB2004/003286 patent/WO2005034965A1/en active Application Filing
-
2012
- 2012-08-17 JP JP2012181003A patent/JP2012236855A/ja active Pending
-
2014
- 2014-08-04 JP JP2014158462A patent/JP2014205721A/ja active Pending
-
2016
- 2016-07-26 JP JP2016146163A patent/JP2016185989A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005032562A1 (en) | 2005-04-14 |
| SI1677806T1 (sl) | 2009-06-30 |
| JP2014205721A (ja) | 2014-10-30 |
| ES2317018T3 (es) | 2009-04-16 |
| PT1677806E (pt) | 2009-01-29 |
| CN1859918A (zh) | 2006-11-08 |
| AU2004277290B2 (en) | 2010-05-13 |
| JP2016185989A (ja) | 2016-10-27 |
| WO2005034965A1 (en) | 2005-04-21 |
| EP1677806B1 (de) | 2008-11-19 |
| EP1677806A4 (de) | 2007-04-04 |
| EP1677806A1 (de) | 2006-07-12 |
| CA2541813A1 (en) | 2005-04-14 |
| CN1859918B (zh) | 2010-07-07 |
| AU2004277290A1 (en) | 2005-04-14 |
| CA2541813C (en) | 2011-12-06 |
| ATE414522T1 (de) | 2008-12-15 |
| DK1677806T3 (da) | 2009-02-23 |
| PL1677806T3 (pl) | 2009-05-29 |
| JP2007507431A (ja) | 2007-03-29 |
| US20050080037A1 (en) | 2005-04-14 |
| JP2012236855A (ja) | 2012-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004017888D1 (de) | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure | |
| DE502007002101D1 (de) | Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen | |
| DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
| DE69613840D1 (de) | Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle | |
| ATE510542T1 (de) | Noribogain zur behandlung von schmerzen und drogenabhängigkeit | |
| ATE119386T1 (de) | Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung. | |
| DE602005010213D1 (de) | Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens | |
| DE60305055D1 (de) | Verwendung von ghrelin zur behandlung von unterernährung von gastrektomiepatienten | |
| CY1107352T1 (el) | Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου | |
| BR0010669A (pt) | Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina | |
| EA201992759A1 (ru) | Ассоциация, включающая кислород и гиалуроновую кислоту, для местного вагинального применения | |
| SE0000601D0 (sv) | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet | |
| RU2008152376A (ru) | Средство против вируса ящура для животных, относящихся к семейству свиней или овец, и способы профилактики и лечения ящура у животных, относящихся к семейству свиней или овец | |
| BR0008443A (pt) | Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética | |
| TW200501934A (en) | Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set | |
| ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
| BR0111900A (pt) | Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca | |
| RU2010144554A (ru) | Средство для предотвращения и/или лечения сосудистых заболеваний | |
| Blatman | Myofascial Trigger Point Injection | |
| TNSN03022A1 (en) | Method for treatment of inflammation | |
| UA30310A (uk) | Спосіб лікування механічної жовтяниці у експериментальних тварин |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |